Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
A dose escalation study to determine the maximum tolerated dose of IMC-RON8 in participants with solid tumors. Participants can either be dosed once a week, or once every other week.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
39 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal